z-logo
open-access-imgOpen Access
Use of radiographic features in COVID-19 diagnosis: Challenges and perspectives
Author(s) -
Sin Guang Chen,
Ju Yu Chen,
Yi Yang,
ChianShiu Chien,
MongLien Wang,
Liang Yu Lin
Publication year - 2020
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 42
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000336
Subject(s) - medicine , covid-19 , radiography , economic shortage , modalities , radiology , medical physics , intensive care medicine , disease , pathology , infectious disease (medical specialty) , social science , linguistics , philosophy , government (linguistics) , sociology , outbreak
The rapid surge and wide spread of the coronavirus disease-2019 (COVID-19) overshadows the entire medical industries worldwide. The stringent medical resources hinder the diagnostic capacity globally, while 84 000 of new cases confirmed within a single day of April 14, 2020. Real-time reverse-transcription polymerase chain reaction (RT-PCR) with is the current first-line diagnosis, but the false-negative rate remains concerned. Radiographic technologies and tools, including computed tomography (CT) and chest X-ray, were applied for initial screening and follow-up, from which the tools provide detail diagnosis with specific pathologic features for staging and treatment arrangement. Although the radiographic imaging is found less sensitive, numerous CT-positive patients were not screened out by RT-PCR initially and later confirmed as COVID-19 positive. Besides, the shortage of sampling kits and the longer turn-over time of PCR examinations in some areas were noticed due to logistic issues and healthcare burden. In this review, we will discuss the challenges and the future perspectives of using radiographic modalities for COVID-19 diagnosis in view of securing human lives amid the crisis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here